Why Pharma Needs to Embrace Transparency Now
Demands continue to mount for more visibility into how drugs are developed, distributed and priced. How will these calls for greater transparency impact the pharmaceutical industry? While it’s too early to say, new requirements seem inevitable. But how will businesses meet these obligations, and how can they begin to prepare?
A surprising answer may come from an unlikely department, and may present new opportunities and rewards.